Baldwin Investment Management, LLC Amgen Inc Transaction History

Baldwin Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $86,929 - $105,952	-385 Reduced 30.08%	895 $216,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $1,145 - $1,455	-5 Reduced 0.39%	1,280 $336,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $76,744 - $84,899	-350 Reduced 21.41%	1,285 $311,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $53,697 - $61,452	-270 Reduced 14.17%	1,635 $368,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $334,325 - $391,702	-1,575 Reduced 45.26%	1,905 $405,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $198,543 - $220,269	-850 Reduced 19.63%	3,480 $848,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1,109 - $1,293	-5 Reduced 0.12%	4,330 $1.08 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $32,457 - $38,650	150 Added 3.58%	4,335 $997,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $982,010 - $1.09 Million	4,185 New	4,185 $1.06 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Investment Management, LLC with notifications on news.